Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China flag China · Delayed Price · Currency is CNY
101.66
-1.53 (-1.48%)
Feb 11, 2026, 4:00 PM EST

SHA:688198 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
589.66500.26369.91295.07251.8181.9
Other Revenue
1.611.610.730.10.020.02
591.28501.88370.64295.17251.82181.92
Revenue Growth (YoY)
45.79%35.41%25.57%17.21%38.42%24.57%
Cost of Revenue
70.2758.5237.6431.3629.6120.21
Gross Profit
521.01443.35333263.81222.21161.71
Selling, General & Admin
187.6154.92131.97123.77131.1683.41
Research & Development
160.06151.4498.8155.1558.928.77
Other Operating Expenses
-6.953.461.251.621.171.06
Operating Expenses
343.42312.22233.5181.64192.04114.69
Operating Income
177.59131.1499.582.1730.1747.02
Interest Expense
-1.02-0.46-0.41-0.08-0.12-
Interest & Investment Income
13.717.3217.6622.5316.4919.55
Currency Exchange Gain (Loss)
0.050.05-0.260--
Other Non Operating Income (Expenses)
2.03-0.16-0.06-0.68-0.05-0.06
EBT Excluding Unusual Items
192.36147.89116.43103.9446.566.51
Gain (Loss) on Sale of Investments
0.350.7410.890.970.34
Gain (Loss) on Sale of Assets
-0.05-0.050.05-0.01-0.020.01
Other Unusual Items
-3.552.22.541.322.31-0.57
Pretax Income
189.11150.79120.02106.1449.7666.29
Income Tax Expense
23.8518.6410.6111.74-1.5110.37
Earnings From Continuing Operations
165.27132.14109.4194.3951.2655.92
Minority Interest in Earnings
15.0714.195.80.73-0.060.61
Net Income
180.33146.33115.2195.1351.256.53
Net Income to Common
180.33146.33115.2195.1351.256.53
Net Income Growth
74.15%27.02%21.11%85.80%-9.42%-10.40%
Shares Outstanding (Basic)
138137136136135134
Shares Outstanding (Diluted)
138137137136135134
Shares Change (YoY)
1.25%-0.29%0.92%0.86%0.44%33.66%
EPS (Basic)
1.311.070.850.700.380.42
EPS (Diluted)
1.311.070.840.700.380.42
EPS Growth
72.00%27.38%20.00%84.21%-9.82%-32.96%
Free Cash Flow
94.52-27.0212.5324.014.2743.07
Free Cash Flow Per Share
0.68-0.200.090.180.030.32
Dividend Per Share
0.8000.8000.8000.5000.3570.143
Dividend Growth
--60.00%40.02%149.90%-
Gross Margin
88.11%88.34%89.84%89.38%88.24%88.89%
Operating Margin
30.04%26.13%26.85%27.84%11.98%25.85%
Profit Margin
30.50%29.16%31.08%32.23%20.33%31.07%
Free Cash Flow Margin
15.98%-5.38%3.38%8.14%1.70%23.67%
EBITDA
202.99150.45110.787.7836.1952.69
EBITDA Margin
34.33%29.98%29.87%29.74%14.37%28.96%
D&A For EBITDA
25.419.3111.195.616.025.67
EBIT
177.59131.1499.582.1730.1747.02
EBIT Margin
30.04%26.13%26.85%27.84%11.98%25.85%
Effective Tax Rate
12.61%12.36%8.84%11.06%-15.64%
Revenue as Reported
591.28501.88370.64295.17251.82181.92
Advertising Expenses
-2.010.371.121.220.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.